This research examines how YWHAZ affects type 1 interferon production in response to RNA viruses, suggesting a new regulatory mechanism.
The activation of IRF3 induced by RIG-I-like receptors is pivotal for type 1 interferon (IFN) production in antiviral immunity. Virus infection leads to type 1 IFN production through inducing the dimerization and subsequent nuclear translocation of IRF3. Following its activation, IRF3 must be tightly regulated to prevent a dysregulated or excessive immune response. Here, we first found that YWHAZ, a member of the 14-3-3 protein family, is a negative regulator of type 1 IFN production by targeting IRF3 signaling. YWHAZ is bound to IRF3 to inhibit the formation of the TBK1-IRF3 complex, the phosphorylation and dimerization of IRF3, as well as the subsequent nuclear translocation. YWHAZ also impeded the KPNA3-IRF3 interaction by binding to KPNA3, thereby inhibiting IRF3 nuclear translocation. The aa 124-184 in YWHAZ was critical for YWHAZ-mediated suppression of type 1 IFNs. These findings reveal the mechanism by which YWHAZ promotes RNA virus replication, thereby advancing our understanding of how YWHAZ mediates innate immune responses.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: